scholarly journals Phylogenetic analysis of multiple FISH markers in oral tongue squamous cell carcinoma suggests that a diverse distribution of copy number changes is associated with poor prognosis

2015 ◽  
Vol 138 (1) ◽  
pp. 98-109 ◽  
Author(s):  
Darawalee Wangsa ◽  
Salim Akhter Chowdhury ◽  
Michael Ryott ◽  
E. Michael Gertz ◽  
Göran Elmberger ◽  
...  
Cancer ◽  
2008 ◽  
Vol 112 (2) ◽  
pp. 345-351 ◽  
Author(s):  
Kyle Rusthoven ◽  
Ari Ballonoff ◽  
David Raben ◽  
Changhu Chen

Cancer ◽  
1999 ◽  
Vol 85 (5) ◽  
pp. 1011-1017 ◽  
Author(s):  
Hiroyuki Mineta ◽  
Katsutoshi Miura ◽  
Ikuko Suzuki ◽  
Satoru Takebayashi ◽  
Hajime Amano ◽  
...  

2009 ◽  
Vol 45 (9) ◽  
pp. 1700-1708 ◽  
Author(s):  
Michael Ryott ◽  
Darawalee Wangsa ◽  
Kerstin Heselmeyer-Haddad ◽  
Johan Lindholm ◽  
Göran Elmberger ◽  
...  

2013 ◽  
Vol 31 (1) ◽  
pp. 169-174 ◽  
Author(s):  
HAOJIE WEN ◽  
YAJUN CHEN ◽  
ZEDONG HU ◽  
QIAO MO ◽  
JINYONG TANG ◽  
...  

2016 ◽  
Vol 14 (2) ◽  
pp. 1567-1573 ◽  
Author(s):  
Zedong Hu ◽  
Zhaoming Zhong ◽  
Shaohui Huang ◽  
Haojie Wen ◽  
Xue Chen ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Soundara Viveka Thangaraj ◽  
Vidyarani Shyamsundar ◽  
Arvind Krishnamurthy ◽  
Vijayalakshmi Ramshankar

AbstractOral Tongue Squamous Cell Carcinoma (OTSCC), a distinct sub-group of head and neck cancers, is characteristically aggressive in nature with a higher incidence of recurrence and metastasis. Recent advances in therapeutics have not improved patient survival. The phenomenon of occult node metastasis, even among the purportedly good prognosis group of early-stage and node-negative tongue tumors, leads to a high incidence of locoregional failure in OTSCC which needs to be addressed. In the current study, transcriptome analysis of OTSCC patients identified the key genes and deregulated pathways. A panel of 26 marker genes was shortlisted and validated using real-time PCR in a prospective cohort of 100 patients. The gene expression was correlated with clinicopathological features including occult node metastasis, survival, and therapeutic outcome. The up-regulation of a panel of 6 genes namely, matrix metalloproteinase 9 (MMP9), Laminin subunit Gamma 2 (LAMC2), Desmoglein 2 (DSG2), Plasminogen Activator Urokinase (PLAU), Forkhead Box M1 (FOXM1), and Myosin 1B (MYO1B) was associated with failure of treatment in the early stage (T1, T2). Up-regulation of Tenacin C (TNC) and Podoplanin (PDPN) was significantly correlated with occult node positivity. Immunohistochemical analysis of LAMC2, MMP9, and E-Cadherin (ECAD) confirmed these markers to be indicators of poor prognosis. We propose this panel of valuable prognostic markers can be clinically useful to identify poor prognosis and occult node metastasis in OTSCC patients.


Sign in / Sign up

Export Citation Format

Share Document